BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 7543560)

  • 1. CD44 variant expression is a common feature of epithelial ovarian cancer: lack of association with standard prognostic factors.
    Cannistra SA; Abu-Jawdeh G; Niloff J; Strobel T; Swanson L; Andersen J; Ottensmeier C
    J Clin Oncol; 1995 Aug; 13(8):1912-21. PubMed ID: 7543560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
    Welsh CF; Zhu D; Bourguignon LY
    J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New CD44 splice variants associated with human breast cancers.
    Iida N; Bourguignon LY
    J Cell Physiol; 1995 Jan; 162(1):127-33. PubMed ID: 7529235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and modulation of CD44 variant isoforms in humans.
    Mackay CR; Terpe HJ; Stauder R; Marston WL; Stark H; Günthert U
    J Cell Biol; 1994 Jan; 124(1-2):71-82. PubMed ID: 7507492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation.
    Terpe HJ; Störkel S; Zimmer U; Anquez V; Fischer C; Pantel K; Günthert U
    Am J Pathol; 1996 Feb; 148(2):453-63. PubMed ID: 8579108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor.
    Stauder R; Eisterer W; Thaler J; Günthert U
    Blood; 1995 May; 85(10):2885-99. PubMed ID: 7537983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44 splice variant expression in clear cell carcinoma of the ovary.
    Rodríguez-Rodríguez L; Sancho-Torres I; Leakey P; Gibbon DG; Comerci JT; Ludlow JW; Mesonero C
    Gynecol Oncol; 1998 Nov; 71(2):223-9. PubMed ID: 9826464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer.
    Friedrichs K; Franke F; Lisboa BW; Kügler G; Gille I; Terpe HJ; Hölzel F; Maass H; Günthert U
    Cancer Res; 1995 Nov; 55(22):5424-33. PubMed ID: 7585612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splice variants of CD44 in human cervical cancer stage IB to IIB.
    Kainz C; Kohlberger P; Sliutz G; Tempfer C; Heinzl H; Reinthaller A; Breitenecker G; Koelbl H
    Gynecol Oncol; 1995 Jun; 57(3):383-7. PubMed ID: 7539775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative splicing of CD44 pre-mRNA in human colorectal tumors.
    Finn L; Dougherty G; Finley G; Meisler A; Becich M; Cooper DL
    Biochem Biophys Res Commun; 1994 Apr; 200(2):1015-22. PubMed ID: 7513991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44 isoform expression in primary and metastatic pancreatic adenocarcinoma.
    Rall CJ; Rustgi AK
    Cancer Res; 1995 May; 55(9):1831-5. PubMed ID: 7537174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of integrins and CD44 isoforms in non-Hodgkin's lymphomas: CD44 variant isoforms are preferentially expressed in high-grade malignant lymphomas.
    Terpe HJ; Koopmann R; Imhof BA; Günthert U
    J Pathol; 1994 Oct; 174(2):89-100. PubMed ID: 7525912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer.
    Dall P; Heider KH; Sinn HP; Skroch-Angel P; Adolf G; Kaufmann M; Herrlich P; Ponta H
    Int J Cancer; 1995 Feb; 60(4):471-7. PubMed ID: 7530237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44ν is an indicator for recurrence in advanced cancer.
    Wu CL; Chao YJ; Yang TM; Chen YL; Chang KC; Hsu HP; Shan YS; Lai MD
    BMC Cancer; 2015 Nov; 15():903. PubMed ID: 26572077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells.
    Fujita N; Yaegashi N; Ide Y; Sato S; Nakamura M; Ishiwata I; Yajima A
    Cancer Res; 1994 Jul; 54(14):3922-8. PubMed ID: 7518345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative RNA splicing of the hyaluronic acid receptor CD44 in the normal human brain and in brain tumors.
    Nagasaka S; Tanabe KK; Bruner JM; Saya H; Sawaya RE; Morrison RS
    J Neurosurg; 1995 May; 82(5):858-63. PubMed ID: 7536236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CD44 in human hepatocellular carcinoma cell lines.
    Haramaki M; Yano H; Fukuda K; Momosaki S; Ogasawara S; Kojiro M
    Hepatology; 1995 May; 21(5):1276-84. PubMed ID: 7537711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy.
    Noordzij MA; van Steenbrugge GJ; Verkaik NS; Schröder FH; van der Kwast TH
    Clin Cancer Res; 1997 May; 3(5):805-15. PubMed ID: 9815753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of two isoforms of CD44 in human endometrium.
    Behzad F; Seif MW; Campbell S; Aplin JD
    Biol Reprod; 1994 Oct; 51(4):739-47. PubMed ID: 7529574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different splice variants of CD44 are expressed in gastrinomas but not in other subtypes of endocrine pancreatic tumors.
    Chaudhry A; Gobl A; Eriksson B; Skogseid B; Oberg K
    Cancer Res; 1994 Feb; 54(4):981-6. PubMed ID: 7508823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.